The COVID-19 Aftermath: Volume I: Ongoing Challenges
Saved in:
| Other Authors: | |
|---|---|
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Cham
Springer International Publishing
2024
Cham Springer |
| Edition: | 1st ed. 2024 |
| Series: | Advances in Experimental Medicine and Biology
1457 |
| Subjects: | |
| Online Access: | DE-634 DE-1102 DE-1028 DE-523 DE-91 DE-19 Volltext |
| Physical Description: | 1 Online-Ressource (XI, 455 p. 113 illus., 33 illus. in color) |
| ISBN: | 9783031619397 |
| ISSN: | 2214-8019 |
| DOI: | 10.1007/978-3-031-61939-7 |
Staff View
MARC
| LEADER | 00000nam a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV049903594 | ||
| 003 | DE-604 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 241014s2024 xx o|||| 00||| eng d | ||
| 020 | |a 9783031619397 |c Online |9 978-3-031-61939-7 | ||
| 024 | 7 | |a 10.1007/978-3-031-61939-7 |2 doi | |
| 035 | |a (ZDB-2-SBL)9783031619397 | ||
| 035 | |a (OCoLC)1466924861 | ||
| 035 | |a (DE-599)BVBBV049903594 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-634 |a DE-1028 |a DE-91 |a DE-19 |a DE-523 |a DE-1102 | ||
| 082 | 0 | |a 610.72 |2 23 | |
| 084 | |a BIO 000 |2 stub | ||
| 245 | 1 | 0 | |a The COVID-19 Aftermath |b Volume I: Ongoing Challenges |c edited by Nima Rezaei |
| 250 | |a 1st ed. 2024 | ||
| 264 | 1 | |a Cham |b Springer International Publishing |c 2024 | |
| 264 | 1 | |a Cham |b Springer | |
| 300 | |a 1 Online-Ressource (XI, 455 p. 113 illus., 33 illus. in color) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Advances in Experimental Medicine and Biology |v 1457 |x 2214-8019 | |
| 650 | 4 | |a Biomedical Research | |
| 650 | 4 | |a Biomaterials-Vaccines | |
| 650 | 4 | |a Therapeutics | |
| 650 | 4 | |a Diagnosis | |
| 650 | 4 | |a Public Health | |
| 650 | 4 | |a Bioethics | |
| 650 | 4 | |a Medicine / Research | |
| 650 | 4 | |a Biology / Research | |
| 650 | 4 | |a Vaccines / Biotechnology | |
| 650 | 4 | |a Biomaterials | |
| 650 | 4 | |a Therapeutics | |
| 650 | 4 | |a Diagnosis | |
| 650 | 4 | |a Public health | |
| 650 | 4 | |a Bioethics | |
| 700 | 1 | |a Rezaei, Nima |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 978-3-031-61938-0 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 978-3-031-61940-3 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 978-3-031-61941-0 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-3-031-61939-7 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SBL | ||
| 940 | 1 | |q ZDB-2-SBL_2024 | |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-035242505 | |
| 966 | e | |u https://doi.org/10.1007/978-3-031-61939-7 |l DE-634 |p ZDB-2-SBL |x Verlag |3 Volltext | |
| 966 | e | |u https://doi.org/10.1007/978-3-031-61939-7 |l DE-1102 |p ZDB-2-SBL |x Verlag |3 Volltext | |
| 966 | e | |u https://doi.org/10.1007/978-3-031-61939-7 |l DE-1028 |p ZDB-2-SBL |x Verlag |3 Volltext | |
| 966 | e | |u https://doi.org/10.1007/978-3-031-61939-7 |l DE-523 |p ZDB-2-SBL |x Verlag |3 Volltext | |
| 966 | e | |u https://doi.org/10.1007/978-3-031-61939-7 |l DE-91 |p ZDB-2-SBL |x Verlag |3 Volltext | |
| 966 | e | |u https://doi.org/10.1007/978-3-031-61939-7 |l DE-19 |p ZDB-2-SBL |x Verlag |3 Volltext | |
Record in the Search Index
| _version_ | 1817704006891339776 |
|---|---|
| adam_text | |
| any_adam_object | |
| author2 | Rezaei, Nima |
| author2_role | edt |
| author2_variant | n r nr |
| author_facet | Rezaei, Nima |
| building | Verbundindex |
| bvnumber | BV049903594 |
| classification_tum | BIO 000 |
| collection | ZDB-2-SBL |
| ctrlnum | (ZDB-2-SBL)9783031619397 (OCoLC)1466924861 (DE-599)BVBBV049903594 |
| dewey-full | 610.72 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 610 - Medicine and health |
| dewey-raw | 610.72 |
| dewey-search | 610.72 |
| dewey-sort | 3610.72 |
| dewey-tens | 610 - Medicine and health |
| discipline | Biologie Medizin |
| doi_str_mv | 10.1007/978-3-031-61939-7 |
| edition | 1st ed. 2024 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000zcb4500</leader><controlfield tag="001">BV049903594</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">241014s2024 xx o|||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783031619397</subfield><subfield code="c">Online</subfield><subfield code="9">978-3-031-61939-7</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-031-61939-7</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SBL)9783031619397</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1466924861</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV049903594</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-634</subfield><subfield code="a">DE-1028</subfield><subfield code="a">DE-91</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-523</subfield><subfield code="a">DE-1102</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610.72</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIO 000</subfield><subfield code="2">stub</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">The COVID-19 Aftermath</subfield><subfield code="b">Volume I: Ongoing Challenges</subfield><subfield code="c">edited by Nima Rezaei</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1st ed. 2024</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cham</subfield><subfield code="b">Springer International Publishing</subfield><subfield code="c">2024</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cham</subfield><subfield code="b">Springer</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XI, 455 p. 113 illus., 33 illus. in color)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Advances in Experimental Medicine and Biology</subfield><subfield code="v">1457</subfield><subfield code="x">2214-8019</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biomedical Research</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biomaterials-Vaccines</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Therapeutics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Diagnosis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Public Health</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bioethics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine / Research</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biology / Research</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccines / Biotechnology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biomaterials</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Therapeutics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Diagnosis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Public health</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bioethics</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rezaei, Nima</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">978-3-031-61938-0</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">978-3-031-61940-3</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">978-3-031-61941-0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-3-031-61939-7</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SBL</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SBL_2024</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-035242505</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-3-031-61939-7</subfield><subfield code="l">DE-634</subfield><subfield code="p">ZDB-2-SBL</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-3-031-61939-7</subfield><subfield code="l">DE-1102</subfield><subfield code="p">ZDB-2-SBL</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-3-031-61939-7</subfield><subfield code="l">DE-1028</subfield><subfield code="p">ZDB-2-SBL</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-3-031-61939-7</subfield><subfield code="l">DE-523</subfield><subfield code="p">ZDB-2-SBL</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-3-031-61939-7</subfield><subfield code="l">DE-91</subfield><subfield code="p">ZDB-2-SBL</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-3-031-61939-7</subfield><subfield code="l">DE-19</subfield><subfield code="p">ZDB-2-SBL</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV049903594 |
| illustrated | Not Illustrated |
| indexdate | 2024-12-06T15:07:06Z |
| institution | BVB |
| isbn | 9783031619397 |
| issn | 2214-8019 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-035242505 |
| oclc_num | 1466924861 |
| open_access_boolean | |
| owner | DE-634 DE-1028 DE-91 DE-BY-TUM DE-19 DE-BY-UBM DE-523 DE-1102 |
| owner_facet | DE-634 DE-1028 DE-91 DE-BY-TUM DE-19 DE-BY-UBM DE-523 DE-1102 |
| physical | 1 Online-Ressource (XI, 455 p. 113 illus., 33 illus. in color) |
| psigel | ZDB-2-SBL ZDB-2-SBL_2024 |
| publishDate | 2024 |
| publishDateSearch | 2024 |
| publishDateSort | 2024 |
| publisher | Springer International Publishing Springer |
| record_format | marc |
| series2 | Advances in Experimental Medicine and Biology |
| spelling | The COVID-19 Aftermath Volume I: Ongoing Challenges edited by Nima Rezaei 1st ed. 2024 Cham Springer International Publishing 2024 Cham Springer 1 Online-Ressource (XI, 455 p. 113 illus., 33 illus. in color) txt rdacontent c rdamedia cr rdacarrier Advances in Experimental Medicine and Biology 1457 2214-8019 Biomedical Research Biomaterials-Vaccines Therapeutics Diagnosis Public Health Bioethics Medicine / Research Biology / Research Vaccines / Biotechnology Biomaterials Public health Rezaei, Nima edt Erscheint auch als Druck-Ausgabe 978-3-031-61938-0 Erscheint auch als Druck-Ausgabe 978-3-031-61940-3 Erscheint auch als Druck-Ausgabe 978-3-031-61941-0 https://doi.org/10.1007/978-3-031-61939-7 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | The COVID-19 Aftermath Volume I: Ongoing Challenges Biomedical Research Biomaterials-Vaccines Therapeutics Diagnosis Public Health Bioethics Medicine / Research Biology / Research Vaccines / Biotechnology Biomaterials Public health |
| title | The COVID-19 Aftermath Volume I: Ongoing Challenges |
| title_auth | The COVID-19 Aftermath Volume I: Ongoing Challenges |
| title_exact_search | The COVID-19 Aftermath Volume I: Ongoing Challenges |
| title_full | The COVID-19 Aftermath Volume I: Ongoing Challenges edited by Nima Rezaei |
| title_fullStr | The COVID-19 Aftermath Volume I: Ongoing Challenges edited by Nima Rezaei |
| title_full_unstemmed | The COVID-19 Aftermath Volume I: Ongoing Challenges edited by Nima Rezaei |
| title_short | The COVID-19 Aftermath |
| title_sort | the covid 19 aftermath volume i ongoing challenges |
| title_sub | Volume I: Ongoing Challenges |
| topic | Biomedical Research Biomaterials-Vaccines Therapeutics Diagnosis Public Health Bioethics Medicine / Research Biology / Research Vaccines / Biotechnology Biomaterials Public health |
| topic_facet | Biomedical Research Biomaterials-Vaccines Therapeutics Diagnosis Public Health Bioethics Medicine / Research Biology / Research Vaccines / Biotechnology Biomaterials Public health |
| url | https://doi.org/10.1007/978-3-031-61939-7 |
| work_keys_str_mv | AT rezaeinima thecovid19aftermathvolumeiongoingchallenges |